North Tees and Hartlepool NHS Foundation Trust

The North Tees and Hartlepool NHS Foundation Trust incorporates University Hospital of North Tees in Stockton-on-Tees and University Hospital of Hartlepool in Hartlepool https://www.nth.nhs.uk/

View Trust Services

This trust offers the following services:

  • Acute services:
    • On-site bowel stenting facilities
  • Diagnostic and pre-operative services:
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Advanced disease services:
    • Dedicated Specialist Advanced Nurse
    • Dedicated Specialist Advanced MDT
    • Dedicated Specialist Advanced Outpatient Clinic
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • Availability of 24 hour palliative care advice

Data Quality

All Patients: Trust Network National
Number of patients in Audit 297 2260 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 85 78 86
– Performance status (%) 94 80 89
Patients having major resection: Trust Network National
Number of patients in Audit 145 1313 19631
ASA grade 1 (%) 4 9 9
ASA grade 2 (%) 50 48 53
ASA grade 3 (%) 41 34 31
ASA grade 4+ (%) 3 3 2
ASA grade not recorded (%) 1 6 4
Data completeness of:
7 Audit items for risk-adjustment (%) 99 82 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit 297 2260 35779
Seen by Clinical Nurse Specialist (%) 89 76 88

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 145 1313 19614
Distant metastases (%) 9 5 5
Urgent or emergency surgery (%) 11 13 15
At least 12 lymph nodes excised (%) 99 82 84
Laparoscopic surgery attempted (%) 90 79 72
Risk-adjusted length of stay > 5 days (%) 32 39 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 74 N/A 10747
Adjuvant chemotherapy (%) 70 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 50 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 34 N/A 22

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 38 N/A 4251
Neoadjuvant therapy (%) 26 N/A 33
Circumferential resection margin: Recorded (%) 97 87 89
Circumferential resection margin: Negative (%) 95 83 83
Rectal volume 36 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 114 1373 19644
APER/Hartmanns (%) 27 39 37

Compare trust outcomes